TLRY Stock Analysis: Buy, Sell, or Hold?
TLRY - Tilray Brands, Inc. Common Stock
$5.32
-0.18 (-3.27%)
▼
5d:
-4.32%
30d:
-21.65%
90d:
-29.16%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 01, 2026
0d
Smart Money Accumulation
TLRY is down 4.9% this week, but smart money is accumulating calls. Top strike: $7 2026-06-18 with 3,711 OI. Call ratio: 62% View Scanner →
Strength: 3.7/10
Get Alerted When TLRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
5 traders called TLRY this week
50% bullish • 3 bearish
50% bullish • 3 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TLRY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: TLRY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: TLRY is currently trading at $5.32, which is considered oversold relative to its 30-day fair value range of $5.72 to $6.99. From a valuation perspective, the stock is trading at a discount (Forward PE: -16.5) compared to its historical average (201.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TLRY is in a strong downtrend. The price is currently testing key support at $5.22. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: TLRY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.04 (+82.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TLRY is in a strong downtrend. The price is currently testing key support at $5.22. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: TLRY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.04 (+82.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.72 -
$6.99
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding TLRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 82.6% below Wall St target ($10.04)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$5.72 -
$6.99
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.22
Resistance Level
$6.32
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-16.52
Wall Street Target
$10.04
(+82.6%)
Revenue Growth (YoY)
-7.8%
Profit Margin
-156.7%
PE vs Historical
-16.5 vs 201.6
CHEAP
Share & Embed Analysis
Last updated: May 15, 2026 2:38 PM ET
Data refreshes hourly during market hours. Next update: 3:38 PM
Data refreshes hourly during market hours. Next update: 3:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
David G Hopkinson
SELL
33556 shares
2026-04-21
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$191 | 63 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$136 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$102 | 59 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 58 HOLD |
Advanced TLRY Option Strategies
Professional options setups generated by AI based on today's TLRY price and gamma walls.
